News
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for the treatment of liver, cardiometabolic diseases and GI oncological indications, ...
ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announced today that a ...
President Donald Trump is holding a rally in Pennsylvania on Friday to celebrate a details-to-come deal for Japan-based ...
Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...
Liver fibrosis is a gradually worsening condition marked by excessive collagen buildup resulting from ongoing liver damage.
Raphael Coin (RAPH), a blockchain project offering fractional ownership in fine art, announced professional race car driver ...
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce another milestone ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Elevate your grad party with these 28 Cute Graduation Centerpiece Ideas You must see! Perfect for memorable celebrations and ...
19d
ZME Science on MSNJust five minutes of junk food advertising are enough to get kids eating more caloriesResearchers have long known that junk food advertising can prompt children to eat more. But a new study, presented this week at the European Congress on Obesity in Málaga, Spain, goes further — ...
-Under the agreement, CRISPR Therapeutics will make an upfront payment of $25 million in cash and $70 million in equity to ...
1d
News-Medical.Net on MSNWhat drives insulin resistance? Proteomics reveals key pathways in human skeletal muscleIdentifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results